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The efﬁ  cacy of malaria control and elimination on is-
lands may depend on the intensity of new parasite inﬂ  ow. 
On the Comoros archipelago, where falciparum malaria re-
mains a major public health problem because of spread of 
drug resistance and insufﬁ  cient malaria control, recent in-
terventions for malaria elimination were planned on Moheli, 
1 of 4 islands in the Comoros archipelago. To assess the 
relevance of such a local strategy, we performed a popula-
tion genetics analysis by using multilocus microsatellite and 
resistance genotyping of Plasmodium falciparum sampled 
from each island of the archipelago. We found a contrasted 
population genetic structure explained by geographic isola-
tion, human migration, malaria transmission, and drug se-
lective pressure. Our ﬁ  ndings suggest that malaria elimina-
tion interventions should be implemented simultaneously on 
the entire archipelago rather than restricted to 1 island and 
demonstrate the necessity for speciﬁ  c  chemoresistance 
surveillance on each of the 4 Comorian islands.
P
lasmodium falciparum causes malaria worldwide; 
250 million cases and ≈1 million deaths occur an-
nually, mostly in sub-Saharan Africa. However, recently 
increased international ﬁ  nancial commitment has revived 
hope for malaria elimination from selected areas to which it 
is endemic, and the feasibility of elimination has become a 
topic of research (1). The successful elimination of malaria 
from several Caribbean islands, Cyprus, Reunion, Mau-
ritius, Maldives, Taiwan, and Singapore in the context of 
the Global Malaria Eradication Program (1955–1968) (2) 
suggests that islands are prime targets for elimination inter-
ventions. Because most parasites among neighboring areas 
are exchanged through human migrations, the geographic 
isolation of islands can limit malaria importation and may 
make control easier (3,4).
Several molecular epidemiologic studies have shown 
that P. falciparum populations are more or less homo-
geneous within malaria-endemic areas and may exhibit 
genetic structure patterns shaped by various transmission 
rates and geographic isolation levels (4–6). Although geo-
graphic isolation may be more relevant on islands than 
within continents, the role of parasite genetic structure in 
malaria-endemic archipelagos or among malaria-endemic 
islands and the nearest continent remains unknown. Past 
failures of malaria elimination in Zanzibar off the coast 
of mainland Tanzania; in Sri Lanka (1); or in Mayotte, a 
France-administered island of the Comoros archipelago 
(7), raise the question of the minimal geographic isolation 
level and the optimal size of intervention area required for 
malaria elimination success. Analysis of malaria epidemi-
ology in Comoros archipelago, where a limited malaria 
elimination program is ongoing, may help to answer this 
question.
Falciparum malaria remains a major public health 
problem on the 4 islands of the Comoros archipelago 
(Grande Comore, Moheli, Anjouan, and Mayotte) (Table 1) 
in the Indian Ocean between Madagascar and the eastern 
coast of Africa. Malaria control has been hampered by the 
emergence of P. falciparum resistance to chloroquine and 
to pyrimethamine/sulfadoxine in the early 1980s (7,10) and 
of Anopheles mosquitoes resistance to DDT. Malaria con-
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trol also has had recurrent political, economic, and struc-
tural weaknesses in the Union of the Comoros (the state 
comprising Grande Comore, Moheli, and Anjouan islands). 
Under stable political and economic conditions, notable ef-
forts in case management and vector control in Mayotte 
failed to eliminate falciparum malaria and to prevent re-
current epidemics (Table 1). During the past 6 years Since 
2004, health authorities in Grande Comore and France 
have introduced an artemisinin-based combined therapy 
(artemether plus lumefantrin) as ﬁ  rst-line treatment for un-
complicated falciparum malaria (7,10). Large-scale distri-
bution of insecticide-treated mosquito nets also has been 
gradually implemented on Grande Comore, Moheli, and 
Anjouan (8), with the goal of reaching up to 89.1% and 
46.3% of the households with at least 1 mosquito net and 1 
insecticide-impregnated mosquito net, respectively, among 
1,620 households from the 3 islands (Comoran National 
Malaria Control Program, unpub. data, 2007).
In Mayotte, anti–Anopheles spp. mosquito larvae 
measures have been strengthened. Finally, by late 2007, a 
controversial malaria elimination project was launched on 
the sole island of Moheli with assistance from China. Mass 
treatment of the residing and disembarking population with 
artemisinin plus piperaquine (Artequick; Artepharm Co., 
Guangzhou, People’s Republic of China) and primaquine 
was initiated without enhancement of vector control. Be-
cause of continual human travel across the archipelago, the 
long-term success of such a spatially limited elimination 
attempt is questionable.
In addition, surveillance of P. falciparum chemosuscep-
tibility has been chaotic and unequal among the islands of 
the archipelago, and results of the few available therapeutic 
efﬁ  cacy tests and in vitro and molecular resistance studies 
often have been discordant. A more rational and efﬁ  cient 
surveillance system is urgently needed. Because Marseille, 
France, houses a Comorian community of 50,000–80,000 
persons who annually import several hundred malaria cas-
es, the city was proposed as a relevant surveillance site for 
chemosusceptibility of P. falciparum imported from Co-
moros (11). However, extrapolating these chemoresistance 
data to the entire archipelago remains difﬁ  cult.
As already proposed for Borneo (12) and the Philip-
pines (13), our main objective was to analyze the genetic 
structure of P. falciparum on the Comoros islands to 1) 
forecast the chances of middle-term and long-term success 
for the current elimination program focalized in Moheli, 
2) guide future malaria elimination programs on the archi-
pelago, and 3) adjust its chemoresistance monitoring and 
treatment policies. Study results also would provide a per-
tinent model for determining which other malaria-endemic 
areas might be eligible for malaria elimination. A second-
ary objective was to assess whether the diversity of the P. 
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Table 1. Epidemiologic and sampling characteristics of 5 sites studied for Plasmodium falciparum malaria, Comoros archipelago and 
Marseille, France
Characteristic Grande Comore Moheli Anjouan Mayotte  Marseille 
Area, km
2 1,148 290 424 374
Total population  330,000  40,000  280,000  190,000  50,000–80,000
No. bites by infected mosquitoes/person*  10–20/y (up to 
200/y) 
10/y (up to 
1/night) 
No data  Low  None 







Total no. reported cases (% confirmed 
cases), 2006* 
51,148 (34)  7,866 (27)  15,408 (19)  496 (100)  84 (100) 
Incidence/1,000 inhabitants, 2006*  150 150 50 3 Null
% P. falciparum malaria cases,* 2006   96 96 96 90 97
Period of sampling, 2007  Apr–May  Apr–May  Apr–May  Entire year  Entire year 
No. patients sampled, 2007  62 61 63 227 111
Median age of sampled patients, y (IQR) ‡  4 (2–14.8)  7.5 (2.6–21)  7 (3.3–18)  19 (15–25)  33 (9.8–40) 
No. sampled patients in site (A) with history 
of recent arrival from another site (B) 
7 17 6 13 111§ 
Anjouan 6 9 – 7
Grande Comore  – 8 5 6
Mayotte 1 1 0 –
Moheli 0 – 2 0
No. randomly genotyped isolates  36 36 36 36 36
*Data from World Malaria Report 2008 (8) and from various Comorian and French official reports and references published in French, all reviewed by the 
first author in a recent, unpublished thesis (Rebaudet S. Molecular epidemiology and population genetics study of Plasmodium falciparum in Comoros 
archipelago. Impacts on malaria control [thesis] [in French]. Marseille (France): Université de la Méditerranée; 2009). Cases for Marseille represent those 
in persons with history of recent arrival from one of the 4 islands.  
†Malaria endemicity levels based on 2–9 years of available parasite prevalence data, according to the World Health Organization classification: 
hypoendemic, 0–10%; mesoendemic, 11%–50%; hyperendemic, 51%–75%; and holoendemic, >75% (9).
‡IQR, interquartile range. 
§Mainly from Grande Comore (S. Rebaudet, pers. comm.). RESEARCH
falciparum strains imported into Marseille were represen-
tative of the P. falciparum populations from Comoros so 
we could evaluate the relevance of distant chemoresistance 
surveillance from Marseille.
We characterized P. falciparum populations from each 
of the 4 islands and from Marseille (imported from the ar-
chipelago) by multilocus microsatellite genotyping. The 
genetic polymorphism of 3 genes involved in P. falciparum 
resistance to chloroquine, pyrimethamine and cycloguanil, 
or sulfadoxine was also investigated.
Materials and Methods
P. falciparum Isolates
The study was conducted in 2007 (before the malaria 
elimination program was launched in Moheli) in each of 
the 4 islands of the Comoros archipelago and in Marseille. 
The protocol was approved by the ethics committee of 
the university hospitals of Marseille and by the Comorian 
Ministry of Health. Blood samples were obtained after in-
formed consent from patients seeking care for symptomatic 
falciparum malaria at healthcare centers of the archipelago 
or at emergency departments of hospitals in Marseille.
Blood samples were absorbed onto Whatman FTA 
Elute absorbent ﬁ  lter paper in Grande Comore, Moheli, 
and Anjouan islands, on Whatman 903 Protein Saver ﬁ  lter 
paper (Whatman Inc., Florham Park, NJ, USA) in Mayotte, 
and collected into Vacutainer tubes (Becton Dickinson, 
Le Pont-De-Claix, France) in Marseille. All samples were 
frozen and kept at –20°C. After eliminating samples with 
missing data or the lowest parasitaemia levels (<0.01%), 
36 isolates per site were randomly chosen for genotyping, a 
sample size considered adequate for the planned population 
genetics analyses.
Collection of Epidemiologic Data
Patient’s age, sex, history of travel across or outside 
the archipelago (during the past year for Grande Comore, 
Moheli, and Anjouan; during the past 3 weeks for Mayotte) 
and history of recent clinical malaria episodes and intake of 
antimalarial drugs (during the previous month) were col-
lected by oral questioning. Distances between each island 
were measured by using Google Earth software.
Genotyping Procedures
DNA was extracted from ﬁ  lter papers according to 
the manufacturer’s recommendations (Whatman Inc.) 
and from whole blood from Vacutainer tubes by using the 
EZNA Blood DNA Kit (Bioﬁ  dal, Vaulx-en-Velin, France). 
Next, the entire genome was ampliﬁ  ed by using the Illustra 
GenomiPhi V2 DNA Ampliﬁ  cation Kit (GE Healthcare, 
Little Chalfont, UK).
Molecular Markers
Length polymorphism was analyzed for 6 complex and 
putatively neutral microsatellite loci previously described 
(4): Pf2689, 7A11, C4M79, Pf2802, TRAP, and C4M69 
(online Appendix Table, www.cdc.gov/EID/content/16/11/
1686-appT.htm). The studied chemoresistance markers 
were the K76 point mutation of the P. falciparum chloro-
quine resistance transporter (Pfcrt) gene (associated with 
P. falciparum resistance to chloroquine) (14); point mu-
tations of P. falciparum dihydrofolate reductase (Pfdhfr) 
gene codons 108, 16, 51, 59, and 164 (associated with P. 
falciparum resistance to pyrimethamine and cycloguanil, 
i.e., proguanil metabolite) (15); and P. falciparum dihy-
dropteroate synthase (Pfdhps) gene codons 436, 437, 540, 
581, and 613 (associated with P. falciparum resistance to 
sulfadoxine) (15) (online Appendix Table).
Genotyping by PCR
Microsatellite loci were ampliﬁ  ed by nested PCR with 
ﬂ  uorescent end-labeled primers before electrophoresis on 
polyacrylamide gels with Genescan-500 LIZ labeled size 
standards on an ABI 3130XL capillary sequencer (Applied 
Biosystems, Warrington, UK) (online Appendix Table). 
Their length was then analyzed by using GENESCAN 
software (Applied Biosystems, Carlsbad, CA, USA), as 
described (4). The Pfcrt gene was ampliﬁ  ed by seminested 
PCR, and the codon 76 mutation was genotyped by using 
a simple PCR-restriction fragment digest assay and ﬂ  uo-
rescent detection of products on an ABI 3130XL capillary 
sequencer, as described (16). The Pfdhps and Pfdhfr genes 
were ampliﬁ  ed by nested PCR, and their mutations were 
genotyped by using a primer extension method, as de-
scribed (17) and electrophoresis on the ABI 3130XL capil-
lary sequencer.
Statistical Analysis
The multiplicity of infection (MOI, i.e., the number of 
parasites genetically distinguishable by different alleles) 
with P. falciparum was estimated for each isolate from the 
microsatellite locus that exhibited the highest number of 
alleles. The mean MOI for each P. falciparum population 
(Grande Comore, Moheli, Anjouan, Mayotte, and Mar-
seille) was then calculated. Each pair of sites was compared 
for MOI by using the Mann-Whitney U test.
For parasites with multiple infection, i.e., >1 allele 
at each locus, we conducted separate subsequent analysis 
considering the following: 1) complete dataset, 2) curtailed 
dataset with single or main clones after elimination of iso-
lates unsuccessfully genotyped at all 6 microsatellite loci, 
or 3) reconstructed multilocus genotypes after elimination 
of samples with impossible reconstruction (>1 allele at >1 
locus with equivocal peak intensities) and elimination of 
unsuccessfully genotyped isolates (Table 1).
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Genetic Diversity
Genetic diversity of the 5 P. falciparum populations 
was assessed by the number of alleles per locus and by the 
Nei unbiased expected heterozygosity index (He) calculat-
ed from allelic frequencies on the 6 microsatellites for com-
plete datasets by using GENETIX software version 4.05 
(18,19). Comparison between He of the 5 different popula-
tions was performed on FSTAT software version 2.9.4 with 
a 1,000 permutations bilateral comparison test (20).
Population Genetic Structure
Population genetic structure was investigated by using 
the Wright F statistic (FST) (21). The FST index was com-
puted for the 6 microsatellite markers and 5 populations 
on FSTAT software version 2.9.4 (20,22) and by using the 
Slatkin index on ARLEQUIN software (23). A canonical 
correspondence analysis of the reconstructed multilocus 
genotypes set was conducted to illustrate measures of pop-
ulation structure (24) by using CANOCO software (25), 
and its graphic representation was performed by using R 
software. A Monte Carlo procedure permuting genotypes 
among the populations was used to test the signiﬁ  cance of 
the canonical axes and estimate the 95% conﬁ  dence inter-
vals of the centroid of each population (25).
Frequency of Mutations Associated 
with Chemoresistance
We estimated the frequency of point mutations on the 
Pfcrt (K76T mutation), Pfdhfr (108 + 59 + 51 triple muta-
tion), and Pfdhps (437 + 540 double mutation) genes. Dif-
ferences among sites were tested by using the Fisher exact 
test.
Associations between FST and Estimations 
of Parasite Flux
The association between genetic distance (transformed 
as FST/[1 – FST]) and the natural log of the geographic dis-
tance in kilometers was investigated for each pair of islands 
according to the isolation-by-distance model (5,12,26). 
When we considered the number of patients in each sam-
pled island (A) with history of recent arrival from each of 
the neighboring islands (B) and thus possibly with import-
ed malaria (Table 1), the relationship between FST and the 
mean proportion of these travelers among patients, calcu-
lated as ([NB→A/NA] + [NA→B/NB])/2, was investigated for 
each pair of islands.
Results
P. falciparum was detected by PCR in each of the 36 
genotyped blood samples from all 5 sites. Microsatellite 
genotyping was complete for 149 (83%) of the 180 samples 
(Table 2).
Mean MOIs
Of the 180 samples, 59 isolates were multi-infected; 
the proportion of multi-infection among islands differed 
substantially (Table 2). The mean MOI ranged from 1.22 in 
Mayotte to 2.11 in Anjouan (Table 3). It was signiﬁ  cantly 
higher in Anjouan than in Grande Comore (p = 0.0015), 
Moheli (p = 0.0051), and Mayotte (p = 0.0001) and higher 
in Marseille than in Mayotte (p = 0.0093).
Genetic Diversity
Genetic diversity (He) of each population, estimated by 
unbiased expected heterozygosity based on allelic frequen-
cies of the 6 microsatellites and the complete dataset, is 
shown in Table 4. The highest diversity was observed for 
Anjouan and Moheli (each He = 0.71) and the lowest diver-
sity for Mayotte (He = 0.63). The mean He was signiﬁ  cantly 
lower for Mayotte than for Marseille (p = 0.04) and lower 
than for the other sites combined (p = 0.001).
Genetic Differentiation among Islands 
and Population Structure
Figure 1 shows the centroid of each falciparum popu-
lation surrounded by its 95% conﬁ  dence interval, and both 
axes were signiﬁ  cant (p = 0.0001 and p = 0.0004 for 1,000 
permutations, respectively). Grande Comore, Moheli, and 
Anjouan nearby centroids suggest closely related popula-
tions. The detached Mayotte centroid suggests a marked 
differentiation from all the other populations.
Figure 2 shows the pairwise differentiation coefﬁ  cients 
(FST) estimated for the 5 parasite populations according to 
the 6 microsatellite loci and the complete dataset (n = 281). 
The number of P. falciparum clones used to calculate FST 
between sites was 50, 53, 76, 44, and 58 in Grande Co-
more, Moheli, Anjouan, Mayotte, and Marseille, respec-
tively. The Moheli parasite population did not differ signif-
icantly from the Grande Comore and Anjouan populations. 
Conversely, the Mayotte population differed signiﬁ  cantly 
from the populations of the 4 other sites. Marseille parasite 
populations differed signiﬁ  cantly from those from all sites 
except Grande Comore. Similar differentiation index were 
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Table 2. Genotyping results of the 5 sites studied for Plasmodium falciparum malaria, Comoros archipelago and Marseille, France 
Characteristic Grande Comore  Moheli Anjouan Mayotte  Marseille  Total
No. randomly genotyped isolates  36 36 36 36 36 180
No. detected parasites  50 53 76 44 58 281
No. single or main clones successfully genotyped  28 20 29 36 36 149
No. reconstructed multilocus genotypes  30 24 40 37 39 170
No. multi-infected isolates  9 10 22 4 14 59RESEARCH
obtained by using a curtailed dataset (n = 149) or recon-
structed multilocus genotypes (n = 170) and by using the 
Slatkin index (data not shown).
Relations between FST and Estimations of Parasite Flux
Association between genetic and geographic distances 
for each pair of islands is shown in Figure 3. No associa-
tion was signiﬁ  cant. The Anjouan–Mayotte pair exhibited a 
large FST despite the close proximity of the 2 islands.
Of the 414 patients sampled in the archipelago, 35 
reported recent travel to neighboring islands (Table 1). 
Figure 3 suggests a negative relationship between the 
mean percentage of travelers among patients and the cor-
responding FST.
Frequency of Point Mutations associated 
with Chemoresistance
Prevalence of Pfcrt,  Pfdhfr, and Pfdhps mutations 
in the 5 P. falciparum study populations are presented in 
Table 5. Prevalence of the Pfcrt mutation (i.e., isolates 
with the 76T allele or with the 76 K, and T alleles) was 
signiﬁ  cantly lower in Anjouan than in the other parasite 
populations (p<0.002). Prevalence of the Pfcrt mutation 
was signiﬁ  cantly higher in Mayotte than in any other popu-
lation (p< 0.0001). The prevalences of the Pfcrt mutation 
in Grande Comore, Moheli, and Marseille did not differ 
signiﬁ  cantly.
When mutated, the Pfdhfr gene frequently exhibited 
the association of the 3 mutations 108N + 59R + 51I. Prev-
alence of this triple mutation was signiﬁ  cantly lower in the 
Anjouan population than in the Grande Comore (p = 0.04), 
Moheli (p = 0.003), or Marseille populations (p = 0.0004). 
Its prevalence also was signiﬁ  cantly higher in Marseille 
than in Mayotte (p = 0.02). The prevalence of Pfdhps gene 
mutations appeared low in the 5 populations.
Multi-infected isolates with genotype ambiguities and 
impossible distinction between associated clones were rare. 
However, prevalence of these mutations varied little, re-
gardless whether these ambiguous multi-infected isolates 
were considered.
Discussion
The mean MOIs remained low for the Comoros archi-
pelago in comparison with African areas, where malaria is 
highly endemic (4), most likely because of moderate levels 
of malaria transmission (4,5). Likewise, the signiﬁ  cantly 
higher MOI in Anjouan may reﬂ  ect a higher level of ma-
laria transmission in the rainy and swampy sampled areas, 
where vector control has for a long time been impaired by 
recurrent island-speciﬁ  c political crises. The genetic di-
versities appeared lower on the archipelago than on most 
of the African continent (4,5,27–30), probably because of 
the geographic isolation of the islands and their lower ma-
laria transmission levels that could limit effective parasite 
population sizes and outbreeding. However, genetic diver-
sities remained higher than in Asia (5,6,12,13) and South 
America (5,31).
The genetic differentiation index (FST) exhibited a con-
trasted genetic structure between the studied P. falciparum 
populations. Genetic distances were low among parasites 
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Table 3. MOIs of Plasmodium falciparum infections for the 5 sites studied, Comoros archipelago and Marseille, France* 
Locus
Grande Comore  Moheli Anjouan Mayotte  Marseille 
No. MOI No. MOI  No. MOI No.    MOI No. MOI 
All 6 loci  36 1.39 36 1.47 36 2.11 36 1.22 36 1.64
Pf2689 34 1.03 27 1.07 36 1.19 36 1.08 36 1.22
7A11 34 1.12 32 1.19 35 1.37 36 1.14 36 1.39
C4M79 34 1.21 25 1.32 33 1.55 36 1.11 36 1.42
Pf2802 31 1.00 23 1.00 32 1.00 36 1.00 36 1.00
TRAP 35 1.42 29 1.14 36 1.67 36 1.08 36 1.19
C4M69 32 1.06 21 1.19 34 1.12 36 1.03 36 1.11
Mean no. alleles per locus  8.5 8 8.5 4.5 7.8
*Based on no. multi-infected isolates as shown in Table 2. MOI, multiplicity of infection (no. multi-infected isolates/no. randomly genotyped isolates);  
no., no. randomly genotyped isolates;  
Table 4. Genetic diversity of Plasmodium falciparum at the 5 sites studied, Comoros Archipelago and Marseille, France* 
Locus
Grande Comore  Moheli Anjouan Mayotte  Marseille 
No. He No. He No. He No. He No. He
All 6 loci  50 0.63 53 0.71 76 0.71 44 0.51 58 0.63
Pf2689 35 0.47 29 0.44 43 0.52 39 0.15 42 0.53
7A11 38 0.81 38 0.85 48 0.82 41 0.41 50 0.87
C4M79 41 0.86 33 0.85 51 0.83 40 0.74 51 0.87
Pf2802 31 0.00 23 0.48 32 0.43 36 0.48 36 0.20
TRAP 39 0.79 33 0.80 57 0.85 39 0.60 43 0.56
C4M69 34 0.87 25 0.82 38 0.84 37 0.68 40 0.77
*No., no. detected parasites. He, Nei unbiased expected heterozygosity index. Elimination of Malaria, Comoros Archipelago
on Grande Comore, Moheli, and Anjouan islands. How-
ever, FSTs among these 3 populations and Mayotte were as 
signiﬁ  cant as between P. falciparum populations of Sen-
egal and Djibouti when the same microsatellite loci were 
used (4) or as between populations of Africa and Southeast 
Asia when other microsatellite loci were used (5). In addi-
tion, the genetic distances between falciparum populations 
across the archipelago seemed associated with the parasite 
ﬂ   ows among islands, estimated from the proportion of 
travelers among sampled patients, in particular for Moheli, 
Grande Comore, and Anjouan.
Our results strongly suggest that despite the insular 
geographic isolation of Moheli and the malaria elimina-
tion program launched in late 2007 on this island only, the 
mass treatment without enhanced vector control may soon 
be impaired by the continuous importation of new parasites 
through intense human migrations. In addition to ﬂ  ights and 
ferries regularly traveling across the archipelago, humans 
in Comoros move mainly by small ﬁ  shing boats, especially 
from and toward Moheli (S. Rebaudet, pers. comm.). Their 
ubiquitous and informal trafﬁ  c makes human ﬂ  ux estima-
tions unreliable (probably several tens of thousands of per-
sons each way annually [S. Rebaudet, pers. comm.]) and 
their control difﬁ  cult. These factors might explain why, 
despite the substantial resources that France has allocated 
in Mayotte to malaria control since the mid-1970s, malaria 
importation to this island could not be stopped and autoch-
thonous falciparum malaria could not be eliminated. The 
disease persists in Mayotte with a hypoendemo-epidemic 
setting, genetically characterized by low MOI, low He, sig-
niﬁ  cant linkage disequilibrium (data not shown), and high 
FSTs, artiﬁ  cially overestimated by the sampling of multiple 
repeated genotypes (data not shown).
The persistent efforts for malaria elimination in Moheli 
can be hypothesized to create a Mayotte-like setting requir-
ing efﬁ  cient vector control to prevent epidemics in a Mo-
helian population that is losing its immunity. In the Union 
of the Comoros, the extension of the elimination program 
based on artemisinin-based combined therapy mass treat-
ment to Grande Comore and Anjouan is being considered 
by Comorian health authorities and their Chinese interlocu-
tors (R. Silaï, pers. comm.). Its success and the prevention 
of epidemics will depend on the rapid and large implemen-
tation of the preventive, diagnostic, and therapeutic mea-
sures planned with the funds granted in 2010 by Round 8 of 
the Global Fund (http://portfolio.theglobalfund.org/Grant/
Index/COM-810-G03-M?lang=en).
Isolation of a speciﬁ  c P. falciparum population before 
planning its elimination needs to be appropriately evaluat-
ed. Results from the present Comorian epidemiologic study 
illustrate how it could be evaluated by a population genet-
ics approach. In that type of geographic setting, population 
genetics studies provide a probably more direct and reliable 
estimation of parasite ﬂ  ows and risk for re-introduction 
than does the evaluation of human population movements 
by sociodemographic methods. Therefore, the relevance 
of parasite inﬂ  ow from Africa (mostly the Tanzania coast, 
Madagascar, or other malaria-endemic areas) should be 
evaluated before the elimination project is extended to the 
rest of the Comoros archipelago. Similar data would also 
be useful for Sri Lanka, Malaysia, Indonesia, the Philip-
pines, Solomon islands, or Vanuatu, several islands where 
national or localized malaria elimination projects are being 
implemented (2).
According to the genetic structure of P. falciparum 
populations in Comoros demonstrated by microsatellite 
genotyping, resistance levels would be expected to be 
fairly similar across the archipelago, except for Mayotte. 
However, the study of Pfcrt and Pfdhfr resistance–asso-
ciated mutations differed markedly, explainable only by 
contrasting levels of drug selective pressure among is-
lands. Indeed, the prevalence of the K76T mutation on 
the Pfcrt gene was high in both Grande Comore and Mo-
heli as found in previous studies (32,33) but substantively 
lower in Anjouan and signiﬁ   cantly higher in Mayotte 
where chloroquine use was massive during 1975–2007 
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Figure 1. Results of canonical correspondence analysis (CCA) of 
Plasmodium falciparum populations from the islands of Grande 
Comore (GC), Moheli (MOH), Anjouan (ANJ), and Mayotte (MAY) 
and from Marseille, France (MARS), according to 6 microsatellite 
loci. CCA is used as a 2-dimensional representation of genetic 
distance between plasmodial populations assessed from 6 
microsatellite loci (Pf2689, C4M79, Pf2802, 7A11, TRAP, and 
C4M69). This representation requires the projection of data from 
6-dimensional space to 2-dimensional space. Canonical axes I and 
II of the new 2-dimensional space are calculated to conserve the 
highest genetic variance between populations after projection of 
data, and their signiﬁ  cance was tested by Monte Carlo permutation 
that also enabled estimation of the 95% conﬁ  dence  intervals 
(ellipses) of the centroid (dots) of each population.RESEARCH
(7,34). Similarly, the prevalence of Pfdhfr triple mutants 
was higher in Moheli than in Anjouan and the prevalence 
of Pfdhfr double or triple mutants higher in Marseille than 
in Grande Comore.
Although no reliable estimation of past use of antima-
larial drugs in Comoros is available, these differences may 
be explained by a greater use in Moheli of pyrimethamine 
(in the sulfadoxine/pyrimethamine combination for malaria 
treatment) and trimethoprim (in cotrimoxazole compound, 
which is widely prescribed in this island as an antimicro-
bial drug) and in Marseille of proguanil (in association 
with chloroquine or atovaquone, used as malaria chemo-
prophylaxis by travelers to the archipelago) (S. Rebaudet, 
pers. comm.). Trimethoprim and proguanil are 2 antifolate 
drugs whose cross-resistance with pyrimethamine has been 
suspected (35,36) and that may have selected these Pfd-
hfr mutations. Because of the contrasting resistance levels 
among islands, the risk for rapid propagation of resistant 
P. falciparum strains across the archipelago suggested by 
the low FSTs among Grande Comore, Moheli, and Anjouan 
(4,5), and the easier selection of multigenic resistance and 
multiresistance from low MOIs limiting the possibilities of 
genetic recombinations that could break apart allele com-
binations (5,37,38), French and Comorian health authori-
ties should organize surveillance of chemoresistance, both 
regular and separated for each island.
Finally, microsatellite genotypes of the P. falciparum 
population in Marseille substantially differed from those 
populations on all islands except Grande Comore. Because 
most of the Comorian inhabitants living in Marseille origi-
nated from Grande Comore, malaria is imported mainly 
from this particular island (S. Rebaudet, pers. comm.). 
Therefore, if we consider that the P. falciparum popula-
tion in Marseille may be representative only of the Grande 
Comore population and the distinct levels of drug pressure 
between Marseille and the other populations, the relevance 
of distant chemosusceptibility surveillance from Marseille 
is likely to be limited.




















Figure 2. Genetic differentiation (Fst) between Plasmodium 
falciparum populations from the islands of Grande Comore (GC), 
Moheli (MOH), Anjouan (ANJ), and Mayotte (MAY) and from 
Marseille, France (MARS), according to 6 microsatellite loci. 
Pairwise comparison among sites that used complete dataset (n 
= 281) and 6 microsatellite loci (Pf2689, C4M79, Pf2802, 7A11, 
TRAP, and C4M69). Departure of FST from 0 tested after 10,000 
bootstrap simulations and by using Bonferroni corrected p 
values obtained after 200 permutations. Difference is signiﬁ  cant 
if adjusted p<0.005. Black arrows indicate negligible (FST<0.01) 
and nonsigniﬁ  cant differentiation. Asterisks (*) and orange arrows 
indicate moderate (0.01<FST<0.1) and/or statistically signiﬁ  cant 
differentiation. Daggers (†) and red arrows indicate important (FST 
>0.1) and signiﬁ  cant differentiation. Plain arrows indicate genetic 
differentiation between the parasite populations of the Comoros 
islands. Dotted arrows indicate genetic differentiation between the 
parasite population imported in Marseille (from Comoros) and either 
the overall parasite population of the entire Comoros archipelago 
(dotted oval and extreme right arrow) or the parasite populations of 
each of the 4 islands.
Figure 3. Relationship between geographic and genetic distances for 
each pair of Comoros islands (top) and between mean percentage 
of travelers among sampled patients and genetic distance for 
each pair of Comoros islands (bottom). Genetic distances were 
calculated as (FST/1 – FST ), where FST is the Wright F statistic. Mean 
percentage of travelers was calculated from the total number of 
sampled patients in one site (NA) with history of recent arrival from 
another site (NB) by using the equation ([NB→A/NA] + [NA→B/NB])/2; 
data in Table 1. GC, Grande Comore; MOH, Moheli; ANJ, Anjouan; 
MAY, Mayotte; Ln, logarithmically transformed.Elimination of Malaria, Comoros Archipelago
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